Brief: Alzinova Submits Request For Pre-IND Meeting With FDA, Applies For EMA Scientific Advice
13/06/2023 07:21
June 13 (Reuters) - Alzinova AB ALZ.ST :
* ALZINOVA SUBMITS REQUEST FOR PRE-IND MEETING WITH FDA AND
APPLIES FOR EMA SCIENTIFIC ADVICE
* PURPOSE OF REGULATORY INTERACTIONS IS TO PREPARE FOR CO'S
PHASE
2 STUDY WITH ALZ-101 VACCINE CANDIDATE BEING DEVELOPED FOR
TREATMENT OF ALZHEIMER'S DISEASE
Source text for Eikon: ID:nMFN68lbpk
Further company coverage: ALZ.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))